Alkermes plc (ALKS) Stock Price, News, Quote & History - Yahoo …

Find the latest Alkermes plc (ALKS) stock quote, history, news and other vital information to help you with your stock trading and investing.

CouponFollow Extension

$31
OFF

Alkermes Price Target Raised To $31 From $28 At BofA - Nasdaq

1 week from now

2 days ago · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer …

nasdaq.com

$355.76
OFF

Alkermes (ALKS) Earnings Date And Reports 2024 - MarketBeat

1 week from now

Alkermes (NASDAQ:ALKS) has a recorded net income of $355.76 million. ALKS has generated $1.95 earnings per share over the last four quarters. ... Alkermes (NASDAQ:ALKS) has a …

marketbeat.com

FAQs about Alkermes plc (ALKS) Stock Price, News, Quote & History - Yahoo … Coupon?

Does NASDAQ use Alkermes plc ordinary shares (AlkS) value to determine compliance?

NASDAQ does not use this value to determine compliance with the listing requirements. Alkermes plc Ordinary Shares (ALKS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ...

Is Alkermes (AlkS) a good stock to buy?

In a report released today, Jason Gerberry from Bank of America Securities maintained a Hold rating on Alkermes (ALKS – Research Report). The company’s shares opened today at $29.23. According to TipRanks, Gerberry is a 4-star analyst with an average return of 2.8% and a 46.90% success rate. ...

Where is Alkermes plc headquartered?

Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Trailing total returns as of 11/11/2024, which may include dividends or other distributions. Benchmark is ...

Is AlkS stock under stock?

ALKS stock is currently under... — Orexin 2 Receptor Agonist ALKS 2680 Demonstrated Clinically Meaningful and Statistically Significant Improvements from Baseline in Mean Sleep Latency Compared to Placebo at All Doses Tested in Both ... ...

Did health Alkermes report more revenue than expected?

Health Alkermes Reported More Revenue Than Expected. Here’s Why the Stock Is Falling. Shares of Alkermes were down 2.74% after the Food and Drug Administration published a warning letter alleging Vivitrol ads didn't include important risk information. If Vivitrol, which is used to prevent relapses in opioi... ...

Is Alkermes a Novo Nordisk company?

DUBLIN , May 2, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. In conne... ...